J&J in talks to start bridging clinical study | India News – Times of India

MUMBAI: Johnson & Johnson is in talks with the Centre to start a bridging clinical study of Janssen Covid-19 vaccine candidate in India quickly, stories Rupali Mukherjee. The drug main had introduced a tie-up with Hyderabad-based Biological E in August final 12 months.
“We stay totally targeted on bringing a secure and efficient Covid-19 vaccine to folks all over the world, if authorised to be used by native well being authorities. We are in discussions with the federal government with the target of beginning a clinical study of our Janssen Covid-19 vaccine, topic to regulatory approvals’’, a J&J spokesperson informed TOI.

You may also like

More in:India

Leave a reply

Your email address will not be published. Required fields are marked *